Related Experiment Video
Updated: Jul 4, 2025

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development
Haider N Dawood1, Ali H Al-Jumaili2, Ahmed H Radhi3
1Al Immamin al kadhimin Medical City, Baghdad, 10011, Iraq.
Pneumococcal disease surveillance is crucial, especially in Iraq, due to vaccine-resistant serotypes. This review identifies circulating pneumococcal serotypes to guide the development of more effective vaccines.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Pneumococcal disease poses a significant global health threat, particularly to vulnerable populations.
- While pneumococcal vaccines have reduced disease burden, serotype replacement and emerging strains necessitate new vaccine development.
- Religious mass gatherings in the Middle East can act as disease transmission hotspots.
Purpose of the Study:
- To review and determine the prevalence of pneumococcal serotypes circulating in Iraq.
- To inform the development and introduction of improved pneumococcal vaccines tailored to the Iraqi population.
- To address the lack of current serotype prevalence data in Iraq.
Main Methods:
- Systematic literature review of existing studies on pneumococcal serotypes in Iraq.
- Analysis of available surveillance data and published research.
- Identification of common and emerging pneumococcal serotypes.
Main Results:
- The review highlights a critical data gap in pneumococcal serotype prevalence in Iraq.
- Identified serotypes may include both vaccine-type and non-vaccine-type strains.
- Understanding regional serotype distribution is essential for public health interventions.
Conclusions:
- Periodic surveillance of pneumococcal serotypes in Iraq is warranted.
- Data on circulating serotypes will aid in evaluating current prevention strategies.
- This review provides a foundation for developing and implementing more effective pneumococcal vaccines in Iraq.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Vaccinations
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...